Gallery NewsGallery Structures
Fast Track Structures
Rodin Therapeutics Applies Insights of Epigenetics to Neurological Disorders Founded by Atlas Venture and Proteros biostructures.
CAMBRIDGE, MA / Martinsried, Germany- June 27, 2013.
Rodin Therapeutics, a biotechnology company applying insights of epigenetics to novel therapeutics for neurological disorders, announced its founding by Atlas Venture and Proteros biostructures. Rodin is founded based on its insight into key epigenetic modulators of CNS function, privileged access to Proteros’ best-in-class structural biology capabilities, and a team with deep CNS drug development and company formation experience. Rodin secured financing from Atlas Venture and Johnson & Johnson Development Corporation (JJDC).